Solid Biosciences Inc.
SLDB
$6.40
$0.091.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -69.90% | -54.77% | -29.87% | -12.78% | -0.48% |
| Total Depreciation and Amortization | -28.65% | 13.63% | -4.88% | -25.01% | -14.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 302.27% | 208.09% | 138.61% | 202.28% | 161.21% |
| Change in Net Operating Assets | 223.87% | 169.31% | 132.14% | 80.75% | 72.72% |
| Cash from Operations | -43.61% | -16.74% | -6.19% | 15.44% | 22.64% |
| Capital Expenditure | 20.48% | 45.51% | 56.83% | 76.33% | 66.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -44.35% | 93.17% | -237.78% | -804.80% | -154.36% |
| Cash from Investing | -41.77% | 92.34% | -266.02% | -130.69% | -132.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -133.33% | -- | -- | -422.73% | -240.91% |
| Issuance of Common Stock | 69.82% | 78.70% | 4,000.61% | 61.35% | 56.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 67.11% | 93.66% | -- | -- | -- |
| Cash from Financing | 75.90% | 85.68% | 3,821.75% | 49.96% | 45.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 887.92% | 297.97% | 107.79% | 154,450.00% | -88.22% |